Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease
Author:
Affiliation:
1. From the Clinical Pharmacology Unit (N.D., I.M.M., V.M., P.L., N.R.J., D.J.W.), University of Edinburgh, Queen’s Medical Research Institute; and the Department of Renal Medicine (J.G.), Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Internal Medicine
Reference41 articles.
1. Chronic kidney disease: the global challenge
2. Preserving renal function in adults with hypertension and diabetes: A consensus approach
3. Leptin and renal disease
4. Control of Hypertension in Adults With Chronic Kidney Disease in the United States
5. Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease;Clinical Science;2024-05-29
2. Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease;Clinical Kidney Journal;2024-03-19
3. Targeting the Endothelin A Receptor in IgA Nephropathy;Kidney International Reports;2023-11
4. Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis;Physiological Reviews;2023-10-01
5. Arterial hypertension and chronic kidney disease: consensus statement on patient management;Systemic Hypertension;2023-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3